Reuters: Gates-backed TB drug to enter late-stage testing

CHICAGO (Reuters) - The first experimental drug that fights both conventional and drug-resistant forms of tuberculosis is advancing to late-stage clinical testing, researchers said on Wednesday, raising hope for a new way to stem the growing threat of drug-resistant TB. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/rtDmTMvKupk/story01.htm

Read More